Podrobno

Genetic background of macular telangiectasia type 2
ID Kunčič, Ajda (Avtor), ID Baloh-Urbančič, Mojca (Avtor), ID Dobovšek Divjak, Darja (Avtor), ID Hudler, Petra (Avtor), ID Debeljak, Nataša (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (2,14 MB)
MD5: C3B3D78A57E93BFDEA88B3B4D4255502
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/1422-0067/26/2/684 Povezava se odpre v novem oknu

Izvleček
Macular telangiectasia type 2 (MacTel) is a slowly progressive macular disorder that is often diagnosed late due to the gradual onset of vision loss. Recent advances in diagnostic techniques have facilitated earlier detection and have shown that MacTel is more common than initially thought. The disease is genetically complex, and multiple variants contribute incrementally to the overall risk. The familial occurrence of the disease prompted the investigation of the genetic background of MacTel. To better understand the molecular milieu of the disease, a literature review of the clinical reports and publications investigating the genetic factors of MacTel was performed. To date, disease-associated variants have been found in genes involved in amino acid (glycine/serine) metabolism and transport, urea cycle, lipid metabolism, and retinal vasculature and thickness. Variants in genes implicated in sphingolipid metabolism and fatty acid/steroid/retinol metabolism have been found in patients with neurological disorders who also have MacTel. Retinal metabolism involves complex biochemical processes that are essential for maintaining the high energy requirements of the retina. Genetic alterations can disrupt key metabolic pathways, leading to retinal cell degradation and the subsequent vision loss that characterizes several retinal disorders, including MacTel. This review article summarizes genetic findings that may allow MacTel to be further investigated as an inherited retinal disorder.

Jezik:Angleški jezik
Ključne besede:retina, macular disorder, macular telangiectasia type 2, MacTel, complex disease, genetic predisposition, genomic biomarkers
Vrsta gradiva:Članek v reviji
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2025
Št. strani:19 str.
Številčenje:Vol. 26, iss. 2, art. 684
PID:20.500.12556/RUL-166771 Povezava se odpre v novem oknu
UDK:617.7
ISSN pri članku:1422-0067
DOI:10.3390/ijms26020684 Povezava se odpre v novem oknu
COBISS.SI-ID:223746819 Povezava se odpre v novem oknu
Datum objave v RUL:24.01.2025
Število ogledov:506
Število prenosov:810
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:International journal of molecular sciences
Skrajšan naslov:Int. j. mol. sci.
Založnik:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:mrežnica, makularna motnja, makularna telangiektazija tipa 2, Mac Tel, kompleksna bolezen, genetska predispozicija, genomski biološki označevalci

Projekti

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:P1-0390
Naslov:Funkcijska genomika in biotehnologija za zdravje

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Program financ.:Young researchers

Financer:University Medical Centre Ljubljana
Program financ.:Tertiary Research and Development Project
Številka projekta:20230137

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj